New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset Obesity
Open Access
- 16 September 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (9) , e12793
Abstract
According to the World Health Organization (WHO) there is a pandemic of obesity with approximately 300 million people being obese. Typically, human obesity has a polygenetic causation. Neutral endopeptidase (NEP), also known as neprilysin, is considered to be one of the key enzymes in the metabolism of many active peptide hormones. An incidental observation in NEP-deficient mice was a late-onset excessive gain in body weight exclusively from a ubiquitous accumulation of fat tissue. In accord with polygenetic human obesity, mice were characterized by deregulation of lipid metabolism, higher blood glucose levels, with impaired glucose tolerance. The key role of NEP in determining body mass was confirmed by the use of the NEP inhibitor candoxatril in wild-type mice that increased body weight due to increased food intake. This is a peripheral and not a central NEP action on the switch for appetite control, since candoxatril cannot cross the blood-brain barrier. Furthermore, we demonstrated that inhibition of NEP in mice with cachexia delayed rapid body weight loss. Thus, lack in NEP activity, genetically or pharmacologically, leads to a gain in body fat. In the present study, we have identified NEP to be a crucial player in the development of obesity. NEP-deficient mice start to become obese under a normocaloric diet in an age of 6–7 months and thus are an ideal model for the typical human late-onset obesity. Therefore, the described obesity model is an ideal tool for research on development, molecular mechanisms, diagnosis, and therapy of the pandemic obesity.Keywords
This publication has 39 references indexed in Scilit:
- Improved Learning and Memory in Aged Mice Deficient in Amyloid β-Degrading Neutral EndopeptidasePLOS ONE, 2009
- AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiencyNature Medicine, 2009
- The Roles of Streptozotocin Neurotoxicity and Neutral Endopeptidase in Murine Experimental Diabetic NeuropathyExperimental Diabetes Research, 2009
- How strong is the association between abdominal obesity and the incidence of type 2 diabetes?International Journal Of Clinical Practice, 2008
- Gastrointestinal regulation of food intakeJournal of Clinical Investigation, 2007
- The genetics of human obesityNature Reviews Genetics, 2005
- Neutral endopeptidase and angiotensin‐converting enzyme – key enzymes terminating the action of neuroendocrine mediatorsExperimental Dermatology, 2004
- Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptideBiological Chemistry, 2004
- The Therapeutic Potential of Candoxatril, a Neutral Endopeptidase Inhibitor, in HumansCardiovascular Drug Reviews, 2000
- Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheepLife Sciences, 1987